I will be wearing the same as I had on last year-Look for a 2 squad unit walking same way but not with the protesters--no doubt in MY MIND--NO ONE will question US. I will be carrying by sling my M-14 Sniper with 30rnd mag--LOADED and one in .and a GLOCK .40 .as ALL my unit will be locked.loaded and ready. WE also will be rolling our Strykers (all weapons hot) and placing them around the areas WE are to secure.
HAS been discussed by my Command( a Marine 3 star(active duty)) ROE and when to step in. 1--NO ROE--if fired on FREE FIRE ZONE 2.USE my discretion on when and IF we step in ..COMMS will be up nation wide and IF NEED BE the shit will hit the fan IF I MOVE to use force to protect the un-armed. WE are READY nationwide but NOT ready --don't have all he people from what I know that can step in and CONTINUE our GOVT.
4JULY2013---11SEPT2013---I and 22 OTHERS dressed in CAMO and carrying semi and FULLY AUTO WEAPONS walked the streets of DC--and NO ONE bothered to "CHECK"US.....we DROVE into DC in several STRYKERS--now WHATS wrong with that picture >..
AND I've been out of the CORPS since 2005 BUT worked for an INTEL AGENCY as an operator and consultant and still am getting updates.
SO I ask HOW HARD do you think it's going to be to get my unit--4 BATTALIONS of SPEC-OPS RECON, ACTIVE DUTY and VETS into DC when the word comes down to move out-IMHO and that of Command EASY .
Semper FI and stay safe--going to need you later! ROFLMAO--YOUNG 70--I will be 67 in \April.
Ahh, the joys of open borders and Democrat leadership.
California is not just a public toilet but now there is evidence that leprosy is on the rise in Los Angeles County.
Barack Obama changed US law in 2016 and allowed immigrants with blistering STDs and leprosy to migrate to the US.
Leprosy, also known as Hansen’s disease, is rarely seen in the United States, but cases continue to emerge in Los Angeles County, a new report says.
“Hansen’s disease still exists, and we need to educate medical students and physicians,” coauthor Dr. Maria Teresa Ochoa from Keck Medical Center of the University of Southern California, Los Angeles, told Reuters Health by email.
Dr. Ochoa and colleagues identified 187 patients with the disease in a review of medical records from their leprosy clinic spanning 1973 to 2018. Most patients were Latino, originating from Mexico, and they experienced a median delay in diagnosis of more than three years, the team reports JAMA Dermatology, online August 7.
Multibacillary leprosy (MB) cases outnumbered paucibacillary leprosy (PB) cases by nearly eight to one (88.6% vs. 11.4%, respectively), and Latino patients were more likely than non-Latino patients to have MB, as were patients from Central or South America (versus other regions).
Most patients (80.7%) received multidrug therapy, and most (92.6%) received antibiotics for more than two years, especially if they had MB.
Only about half of patients (56.7%) had World Health Organization (WHO) grade 0 disability (no signs or symptoms suggestive of leprosy or disability) at the one-year follow-up, whereas 16.0% had grade 1 disability (loss of protective sensation) and 26.2% had grade 2 disability (visible deformity) at the last follow-up.
Among the patients who lost protective sensation, 87.7% (50/57) did not regain it following therapy.